DK582481A - Chimaerisk polypeptid,fremgangsmaade til dets fremstilling,kloningsmedium og mikrobielle transformanter til anvendelse ved fremgangsmaaden samt fremgangsmaade til fremstilling af humant insulin - Google Patents

Chimaerisk polypeptid,fremgangsmaade til dets fremstilling,kloningsmedium og mikrobielle transformanter til anvendelse ved fremgangsmaaden samt fremgangsmaade til fremstilling af humant insulin

Info

Publication number
DK582481A
DK582481A DK582481A DK582481A DK582481A DK 582481 A DK582481 A DK 582481A DK 582481 A DK582481 A DK 582481A DK 582481 A DK582481 A DK 582481A DK 582481 A DK582481 A DK 582481A
Authority
DK
Denmark
Prior art keywords
procedure
manufacturing
transformers
microbial
human insulin
Prior art date
Application number
DK582481A
Other languages
Danish (da)
English (en)
Inventor
D V Goeddel
K Itakura
D G Kleid
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK582481A publication Critical patent/DK582481A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK582481A 1981-01-02 1981-12-30 Chimaerisk polypeptid,fremgangsmaade til dets fremstilling,kloningsmedium og mikrobielle transformanter til anvendelse ved fremgangsmaaden samt fremgangsmaade til fremstilling af humant insulin DK582481A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22204481A 1981-01-02 1981-01-02

Publications (1)

Publication Number Publication Date
DK582481A true DK582481A (da) 1982-08-13

Family

ID=22830549

Family Applications (1)

Application Number Title Priority Date Filing Date
DK582481A DK582481A (da) 1981-01-02 1981-12-30 Chimaerisk polypeptid,fremgangsmaade til dets fremstilling,kloningsmedium og mikrobielle transformanter til anvendelse ved fremgangsmaaden samt fremgangsmaade til fremstilling af humant insulin

Country Status (12)

Country Link
EP (1) EP0055945A3 (ja)
JP (1) JPS57163352A (ja)
KR (1) KR830007828A (ja)
AU (1) AU7914581A (ja)
DK (1) DK582481A (ja)
ES (1) ES8401777A1 (ja)
FI (1) FI814172L (ja)
GR (1) GR78327B (ja)
IL (1) IL64634A (ja)
NZ (1) NZ199391A (ja)
PH (1) PH20660A (ja)
ZA (1) ZA818953B (ja)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
CA1204682A (en) * 1981-06-19 1986-05-20 Saran A. Narang Adaptors, and synthesis and cloning of proinsulin genes
US4532207A (en) * 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
WO1983003413A1 (en) * 1982-03-31 1983-10-13 Genetics Inst Creation of dna sequences encoding modified proinsulin precursors
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
US4758512A (en) * 1984-03-06 1988-07-19 President And Fellows Of Harvard College Hosts and methods for producing recombinant products in high yields
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
DE3716722A1 (de) * 1987-05-19 1988-12-01 Hoechst Ag Gentechnologisches verfahren zur herstellung von angiogeninen
US6875589B1 (en) 1988-06-23 2005-04-05 Hoechst Aktiengesellschaft Mini-proinsulin, its preparation and use
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
US5514646A (en) * 1989-02-09 1996-05-07 Chance; Ronald E. Insulin analogs modified at position 29 of the B chain
CA2051375C (en) * 1989-05-04 2000-09-12 Dennis J. Henner Process and compositions for the isolation of human relaxin
US5126249A (en) * 1989-05-09 1992-06-30 Eli Lilly And Company Enzymatic removal of a protein amino-terminal sequence
EP0600372B1 (de) 1992-12-02 1997-02-05 Hoechst Aktiengesellschaft Verfahren zur Gewinnung von Proinsulin mit korrekt verbundenen Cystinbrücken
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
KR0150565B1 (ko) * 1995-02-15 1998-08-17 김정재 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
KR100253916B1 (ko) * 1997-12-29 2000-05-01 김충환 사람 인슐린 전구체의 제조방법
IL138658A0 (en) 1998-03-31 2001-10-31 Tonghua Gantech Biotechnology Chimeric protein
DE19838097A1 (de) 1998-08-24 2000-03-02 Hoechst Marion Roussel De Gmbh Verfahren zur chromatographischen Reinigung von Insulinen
JP3406244B2 (ja) 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
CN1415019A (zh) * 1999-12-29 2003-04-30 诺沃挪第克公司 用于生产在酵母中具有改进发酵产量的胰岛素前体和胰岛素前体类似物的方法
US7378390B2 (en) 1999-12-29 2008-05-27 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
US6521738B2 (en) 1999-12-29 2003-02-18 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogs
US6777207B2 (en) 1999-12-29 2004-08-17 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
JP2003528149A (ja) 2000-03-24 2003-09-24 ジェネンテック・インコーポレーテッド 軟骨性疾患の治療のためのインスリンの使用
US6821755B2 (en) * 2000-07-27 2004-11-23 Boehringer Ingelheim International Gmbh Preparation of a recombinant protein in a prokaryotic host cell
AR025646A1 (es) 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
KR100449454B1 (ko) * 2000-10-02 2004-09-21 이현철 단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터
WO2002079251A2 (en) * 2001-04-02 2002-10-10 Novo Nordisk A/S Method for making human insulin precursors
US7105314B2 (en) 2001-04-02 2006-09-12 Novo Nordisk A/S Method for making human insulin precursors
CN100395263C (zh) 2003-01-31 2008-06-18 欧加农股份有限公司 缺氧条件下的蛋白质分离方法
EP1910550A4 (en) 2005-07-21 2009-11-04 Abbott Lab MULTIGENIC EXPRESSION COMPRISING SORF CONSTRUCTS AND METHODS USING POLYPROTEINS, PRO-PROTEINS, AND PROTEOLYSIS
BRPI0616054B8 (pt) 2005-09-14 2021-05-25 Sanofi Aventis Deutschland processo para a preparação de insulina, um análogo de insulina ou um derivado de insulina, tripsina porcina, método para sua produção, dna e vetor
JP5864834B2 (ja) 2006-09-22 2016-02-17 ノボ・ノルデイスク・エー／エス プロテアーゼ耐性のインスリンアナログ
CN101173006B (zh) * 2006-10-30 2011-12-21 江苏万邦生化医药股份有限公司 一种重组人胰岛素的制备方法
US10100098B2 (en) 2006-12-13 2018-10-16 Stelis Biopharma Private Limited Insulin production methods and proinsulin constructs
US7790677B2 (en) 2006-12-13 2010-09-07 Elona Biotechnologies Insulin production methods and pro-insulin constructs
DK2201120T3 (en) 2007-09-21 2014-03-17 Cadila Healthcare Ltd GCSF fusion protein systems which are suitable for high expression of the peptides
EP2340033B1 (en) 2009-06-26 2013-10-09 Novo Nordisk A/S PREPARATION COMPRISING INSULIN, NICOTINAMIDE AND Arginine
JP2014501239A (ja) 2010-12-14 2014-01-20 ノヴォ ノルディスク アー／エス インスリン、ニコチンアミドおよびアミノ酸を含む製剤
WO2012080320A1 (en) 2010-12-14 2012-06-21 Novo Nordisk A/S Fast-acting insulin in combination with long-acting insulin
DK2739646T3 (en) 2011-05-10 2018-02-26 Stefan Hermann COMPREHENSIVE BUFFER SYSTEM FOR RENATURING HUMAN PROINSULIN OR PROINSULIN DERIVATIVES
WO2013186138A1 (en) 2012-06-14 2013-12-19 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and arginine
JP2016183118A (ja) * 2015-03-25 2016-10-20 東ソー株式会社 増殖因子前駆体のリフォールディング方法
EP3344651B1 (en) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds
KR20190036956A (ko) 2017-09-28 2019-04-05 한미약품 주식회사 지속형 단쇄 인슐린 아날로그 및 이의 결합체
EP3845240A4 (en) 2018-09-12 2021-11-03 Amphastar Nanjing Pharmaceuticals, Inc. NEW STRUCTURE OF PROINSULIN ASPARTE AND METHOD FOR PREPARING INSULIN ASPARTE
CA3166496A1 (en) 2019-12-30 2021-07-08 Gan & Lee Pharmaceuticals Co., Ltd. Long-acting glp-1 compound
KR20220121833A (ko) 2019-12-30 2022-09-01 간 앤 리 파마슈티칼스 컴퍼니, 리미티드 인슐린 유도체

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU257278A (en) * 1977-11-08 1984-02-29 Genentech Inc Process for obtaining a recombinat clone carrier
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
IE48385B1 (en) * 1978-08-11 1984-12-26 Univ California Synthesis of a eucaryotic protein by a microorganism
GR70279B (ja) * 1979-09-12 1982-09-03 Univ California
DE3001928A1 (de) * 1980-01-19 1981-08-06 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
CA1200773A (en) * 1980-02-29 1986-02-18 William J. Rutter Expression linkers

Also Published As

Publication number Publication date
NZ199391A (en) 1985-12-13
EP0055945A3 (en) 1982-09-15
ES508446A0 (es) 1984-01-01
KR830007828A (ko) 1983-11-07
PH20660A (en) 1987-03-23
IL64634A0 (en) 1982-03-31
AU7914581A (en) 1982-07-08
ES8401777A1 (es) 1984-01-01
ZA818953B (en) 1983-02-23
GR78327B (ja) 1984-09-26
FI814172L (fi) 1982-07-03
JPS57163352A (en) 1982-10-07
IL64634A (en) 1986-03-31
EP0055945A2 (en) 1982-07-14

Similar Documents

Publication Publication Date Title
DK582481A (da) Chimaerisk polypeptid,fremgangsmaade til dets fremstilling,kloningsmedium og mikrobielle transformanter til anvendelse ved fremgangsmaaden samt fremgangsmaade til fremstilling af humant insulin
NO158619C (no) Varmeisolerende legeme og fremgangsmaate for fremstilling derav.
NO158561C (no) Flytende sjampo og fremgangsmaate til fremstilling derav.
DK304678A (da) Semisubnersubelt fartoej til roerlaegning paa havbunden og fremgangsmaade til dets anvendelse
NO154425C (no) Fibroest aktivert karbon og fremgangsmaate til dets fremstilling.
DK116282A (da) Kosmetisk praeparat og fremgangsmaade til dets fremstilling
NO812288L (no) Fremgangsmaate til oppvarmning, og apparat for gjennomfoering av fremgangsmaaten.
DK98182A (da) Fungicidt praeparat,fremgangsmaade til dets fremstilling samt anvendelse deraf
DK457581A (da) 4,5-polymethylen-4-isothiazolin-3-oner fremgangsmaade til deres fremstilling og deres anvendelse
NO893748D0 (no) Forbedret nedslipbart belegg og fremgangsmaate til dets fremstilling.
NO853546L (no) Bis-(2-etylamino-4-dietylamino-s-triazin-6-yl), fremgangsm ¨te til dets fremstilling, dets anvendelse og vulkaniserba re blandinger som inneholder det.
DK397086D0 (da) 1-aryl-pyrazoler, deres fremstilling og anvendelse til bekaempelse af skadelige organismer
DK459782A (da) Antiprotozoelle forbindelser, fremgangsmaade til deres fremstilling samt deres anvendelse
NO862976D0 (no) Oksalkylerte polyesteraminer, fremgangsmaate til deres fremstilling og deres anvendelse.
DK589483D0 (da) Mikrobiel loebe, fremgangsmade til fremstilling deraf og plasmider til anvendelse ved fremgangsmaden
NO822796L (no) Aminoorganoaminosilaner, fremgangsmaate til deres fremstilling og deres anvendelse
DK342182A (da) Dispergeringsmiddel, fremgangsmaade til fremstilling heraf samt dets anvendelse
DK509985D0 (da) Antibiotisk polypeptid, fremgangsmaade til dets fremstilling samt dets anvendelse
DK262784A (da) Mikrobiologisk fremstillet d-2-hydroxy-4-methylpentansyredehydrogenase, fremgangsmaade til dets udvinding og dets anvendelse
IT8125226A0 (it) Valvola di controllo sub-superficiale e procedimento per il suo impiego.
DK400786D0 (da) Udtrykkelsesvektorer til anvendelse i e.coli
DK526383A (da) Staerkt opvarmeligt braendstof-behandlingselement, isaer for med flydende braendstof forsynet forgasningsbraender, og fremgangsmaade til dets fremstilling
DK179784D0 (da) Krystallinsk zinksilicat, fremgangsmade til dets fremstilling samt dets anvendelse
NO150784C (no) Aromadestillat og fremgangsmaate til dets fremstilling
NO885088D0 (no) Omslagsmateriale, fremgangsmŸte for dets fremstilling og fremgangsmŸte til bruk av materialet.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment